GO
Loading...

Eli Lilly and Co

More

  • Midday Glance: Pharmaceuticals companies Friday, 20 Mar 2015 | 1:25 PM ET

    Baxter International Inc. fell$. 03 or percent, to $67.95. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $68.43. Eli Lilly& Co. rose $1.35 or 1.8 percent, to $75.57.

  • March 20- An experimental drug from Biogen Idec Inc became the first Alzheimer's treatment to significantly slow cognitive decline and reduce what is believed to be brain-destroying plaque in patients with early and mild forms of the disease, according to a small study likely to reignite hopes of a treatment. Biogen is entering a field littered with...

  • Early Glance: Pharmaceuticals companies Friday, 20 Mar 2015 | 10:19 AM ET

    Baxter International Inc. rose$. 23 or. 3 percent, to $68.21. Bristol-Myers Squibb Co. rose$. 45 or. 7 percent, to $68.77. Eli Lilly& Co. rose$. 52 or. 7 percent, to $74.74.

  • March 20- An experimental drug from Biogen Idec became the first Alzheimer's treatment to significantly slow cognitive decline and reduce what is believed to be brain-destroying plaque in patients with early and mild forms of the disease, according to a small study likely to reignite hopes of a treatment. Biogen is entering a field littered with expensive...

  • Midday Glance: Pharmaceuticals companies Thursday, 19 Mar 2015 | 2:00 PM ET

    Baxter International Inc. fell$. 62 or. 9 percent, to $67.94. Bristol-Myers Squibb Co. fell$. 21 or. 3 percent, to $68.26. Eli Lilly& Co. rose$. 38 or. 5 percent, to $73.92.

  • Early Glance: Pharmaceuticals companies Thursday, 19 Mar 2015 | 10:22 AM ET

    Baxter International Inc. fell$. 38 or. 6 percent, to $68.17. Bristol-Myers Squibb Co. fell$. 13 or. 2 percent, to $68.34. Eli Lilly& Co. fell$. 58 or. 8 percent, to $72.96.

  • Midday Glance: Pharmaceuticals companies Wednesday, 18 Mar 2015 | 2:23 PM ET

    Baxter International Inc. fell$. 81 or 1.2 percent, to $67.66. Bristol-Myers Squibb Co. fell$. 46 or. 7 percent, to $67.17. Eli Lilly& Co. rose$. 41 or. 6 percent, to $71.25.

  • Early Glance: Pharmaceuticals companies Wednesday, 18 Mar 2015 | 11:37 AM ET

    Baxter International Inc. fell$. 21 or. 3 percent, to $68.26. Bristol-Myers Squibb Co. fell$. 22 or. 3 percent, to $67.40. Eli Lilly& Co. rose$. 42 or. 6 percent, to $71.26.

  • Final Glance: Pharmaceuticals companies Tuesday, 17 Mar 2015 | 6:16 PM ET

    Baxter International Inc. rose$. 04 or. 1 percent, to $68.47. Bristol-Myers Squibb Co. fell$. 41 or. 6 percent, to $67.62. Eli Lilly& Co. fell$. 23 or. 3 percent, to $70.84.

  • Midday Glance: Pharmaceuticals companies Tuesday, 17 Mar 2015 | 2:32 PM ET

    Baxter International Inc. rose$. 26 or. 4 percent, to $68.69. Bristol-Myers Squibb Co. fell$. 54 or. 8 percent, to $67.50. Eli Lilly& Co. fell$. 36 or. 5 percent, to $70.71.

  • LONDON, March 17- Other big drugmakers may be reshaping their businesses but Novo Nordisk's focus on diabetes will get even bigger in the coming decade, according to the man most likely to be the Danish company's next boss. Kaare Schultz, who was made deputy chief executive in January 2014 and is the frontrunner to eventually succeed 60- year-old Lars Sorensen,...

  • Early Glance: Pharmaceuticals companies Tuesday, 17 Mar 2015 | 10:28 AM ET

    Baxter International Inc. fell$. 21 or. 3 percent, to $68.22. Bristol-Myers Squibb Co. fell$. 46 or. 7 percent, to $67.57. Eli Lilly& Co. fell$. 16 or. 2 percent, to $70.91.

  • *Backers include British govt, GSK, J&J, Pfizer, Lilly, Biogen. Drug companies involved include GlaxoSmithKline, Johnson& Johnson, Eli Lilly, Pfizer and Biogen Idec. The initiative, announced by Britain's health minister Jeremy Hunt at a meeting in Geneva on Tuesday, follows a Group of Eight nations conference in London in December 2013 that set a goal of finding a...

  • TRENTON, N.J.— Major drugmakers, the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or even a cure for the mind-robbing disease within a decade. Jeremy Hunt, the UK health secretary, was to announce the new fund Tuesday in Geneva at the World Health...

  • LONDON, March 17- The world's first venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $100 million with the backing of the British government and several of the world's leading drugmakers. Drug companies involved include GlaxoSmithKline, Johnson& Johnson, Eli Lilly, Pfizer and Biogen Idec. The initiative, announced by...

  • Final Glance: Pharmaceuticals companies Monday, 16 Mar 2015 | 6:03 PM ET

    Baxter International Inc. rose $1.07 or 1.6 percent, to $68.43. Bristol-Myers Squibb Co. rose $1.16 or 1.7 percent, to $68.03. Eli Lilly& Co. rose $1.18 or 1.7 percent, to $71.07.

  • Midday Glance: Pharmaceuticals companies Monday, 16 Mar 2015 | 1:19 PM ET

    Baxter International Inc. rose$. 74 or 1.1 percent, to $68.10. Bristol-Myers Squibb Co. rose $1.03 or 1.5 percent, to $67.90. Eli Lilly& Co. rose $1.34 or 1.9 percent, to $71.23.

  • Early Glance: Pharmaceuticals companies Monday, 16 Mar 2015 | 10:34 AM ET

    Baxter International Inc. rose$. 93 or 1.4 percent, to $68.29. Bristol-Myers Squibb Co. rose$. 87 or 1.3 percent, to $67.74. Eli Lilly& Co. rose $1.14 or 1.6 percent, to $71.03.

  • LONDON, March 14- Long-term use of AstraZeneca's drug Brilinta can cut the risk of death, another heart attack or stroke in patients with a history of past attacks by 16 percent, a keenly awaited clinical trial showed on Saturday. The finding may boost sales of the blood-thinner, which AstraZeneca is relying on to drive growth, although doctors must balance its...

  • March 4- Vanda Pharmaceuticals Inc said its experimental atopic dermatitis drug failed a mid-stage study to treat chronic itching. It affects between 9 and 30 percent of the U.S. population, according to the National Institutes of Health. The company regained the U.S. and Canada rights for its schizophrenia drug Fanapt from Novartis AG late last year.